Skip to content
Psilocybin Technology
Menu
  • Home
  • Contact us about Psilocybin Science and Technology

Category: Mushrooms

Business / Mushrooms / Psilocybin / Research

Wuhan Signs LOI with Biodelta One Month after Launching Psilocybin Division

On May 17, 2019, Wuhan General Group (“Wuhan”) announced signing a Letter of Intent (“LOI”) with Biodelta Nutraceuticals, Ltd.  This announcement follows Wuhan’s April 5, 2019 announcement that its wholly-owned …

Business / Mushrooms / Psilocybin / Research / State of the Art

Investing in Psychedelics, Psilocybin, or Magic Mushrooms

** See also recent article on “Investing in Psychedelics – a 2020 Perspective” ** [Updated December 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity …

Mushrooms / Psilocybin

Arguments Against Magic Mushrooms or Psilocybin?

The scientific community universally agrees that psilocybin and/or magic mushrooms have enormous potential for treating some of the world’s biggest health problems. Furthermore, scientists agree that psychedelics (like magic mushrooms, …

Business / Mushrooms / Psilocybin

$800 Million Valuation for First Psilocybin Company?

Recent developments in science and policy reform suggest that “magic mushrooms” and psilocybin technology will evolve into a psilocybin industry.  Investments by several early movers illustrate that a psilocybin industry …

Business / Molecules vs. Mushrooms / Mushrooms / Psilocin / Psilocybin / Psilocybin Chemistry / Psilocybin Derivatives / Psilocybin Science / Research

Psilacetin and Psilocybin — Two Equivalent Means for Administering Psilocin

The molecule Psilacetin (aka 4-AcO-DMT or O-Acetylpsilocin) is a synthetic psilocybin derivative.  Like psilocybin, psilacetin serves as a prodrug of psilocin, which is the primary active molecule responsible for the …

Business / Cognitive Enhancement / Microdosing / Molecules vs. Mushrooms / Mushrooms / Psilocybin / Treatment

Tim Ferriss and Psychedelics

Best-selling author, entrepreneur, and angel investor Tim Ferriss praises the benefits of psychedelics.  Mr. Ferriss financially supports psychedelic research and he methodically uses psychedelics for treating depression and enhancing cognition.  …

Business / Depression / Molecules vs. Mushrooms / Mushrooms / Psilocybin / Research / State of the Art

No Magic Mushroom Monopoly

No Magic Mushroom Monopoly Relax. No one is trying to monopolize magic mushrooms.  COMPASS Pathways is not trying to monopolize magic mushrooms.  Renewed interest in psychedelic medicine (e.g., psilocybin) is not part …

Molecules vs. Mushrooms / Mushrooms / Psilocin / Psilocybin / Psilocybin Chemistry / Psilocybin Derivatives

Three Key Points for Journalists Reporting on “Magic Mushrooms” or Psilocybin

Three Points to Remember when Writing about Psilocybin or “Magic Mushrooms” For good reason, the mainstream media have taken an increased interest in psychedelic sciences.  Given that many journalists are …

Molecules vs. Mushrooms / Mushrooms / Psilocybin Chemistry / Psilocybin Derivatives / Research / State of the Art

Different Magic Mushrooms – Different Chemical Cocktails – Different Effects?

Importance of Mushroom Chemotype for Clinical Experience Currently, research and development in the psilocybin space follows the traditional pharmaceutical model — using one, pure, synthetic ingredient, i.e., synthetic psilocybin.  See Compass.  …

Cognitive Enhancement / Mass / Microdosing / Molecules vs. Mushrooms / Mushrooms / Psilocybin / Psilocybin Chemistry / State of the Art / Unmet Need

Science Trends Illustrates Problems Defining and Describing Microdosing

Microdosing Described by Alex Bolano of Science Trends On October 29th, Science Trends published an article by Alex Bolano about how microdosing psychedelic mushrooms could stimulate creative thought. At a …

Posts navigation

Older posts
Newer posts

Recent Posts

  • Nova Mentis Launches Entourage Effect Research
  • Graham Pechenik and Noah Potter discuss Psychedelic Patents
  • MindMed – Two Steps Closer to Next Generation Magic Mushroom Formulations
  • COMPASS Pathways’ $100+ Million Crystalline Form Patent
  • MagicMed – The First Psychedelic Patent Troll?

Recent Comments

  • Psilocybin Expert on Taking Pure Psilocybin is Different from Eating Magic Mushrooms
  • jim on Cannabis and Magic Mushrooms – A Near Perfect Analogy
  • jeff on China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
  • jeff on Chemical & Engineering News Discusses Entourage Effect
  • jeff on Psilocybin Clinical Trials Approved by FDA

Archives

  • January 2021
  • November 2020
  • September 2020
  • July 2020
  • February 2020
  • January 2020
  • December 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • November 2017
  • October 2017

Categories

  • Aeruginascin
  • Anxiety
  • Business
  • Cognitive Enhancement
  • Decriminalization
  • Depression
  • Law
  • Legalization
  • Mass
  • Microdosing
  • Molecules vs. Mushrooms
  • Mushrooms
  • Patents
  • Psilocin
  • Psilocybin
  • Psilocybin Chemistry
  • Psilocybin Derivatives
  • Psilocybin Science
  • Research
  • State of the Art
  • Treatment
  • Uncategorized
  • Unmet Need
  • Wood Lover Paralysis

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Copyright © 2021 Psilocybin Technology – OnePress theme by FameThemes